PEER SIMPLIFIED GUIDELINE: MANAGING OPIOID USE DISORDER IN PRIMARY CARE
- Guideline
- Guideline Summary
- Opioid Use Disorder Primary Care Pathway and Buprenorphine/Naloxone Induction Flow Diagram
- Prescription Opioid Misuse Index (POMI)
- Guideline videos and webinars:
- OUD Guideline Summary Video
- OATrageously Rewarding Medicine – Treating OUD in Primary Care Webcast (from PEIP 2019)
- CFPC Clinical Webinar: Managing Opioid Use Disorder in Primary Care (PEER Guideline Overview)
- CFPC Clinical Webinar: An Office Base Induction of Buprenorphine/Naloxone using PEER Guideline
TOOLS FOR ASSESSING WITHDRAWAL
AMA ACTT OPIOID PROCESS IMPROVEMENT CHANGE PACKAGE
- Opioid Process Improvement Change Package
- Opioid Processes Change Package Summary
- Opioid Change Package Self-Directed Course
AHS HARM REDUCTION AND RECOVERY MODULE FOR PRIMARY CARE
PEER SIMPLIFIED DECISION AID: OSTEOARTHRITIS TREATMENT OPTIONS IN PRIMARY CARE
- Decision Aid: Osteoarthritis Treatment Options
- Umbrella Systematic Review: Managing Osteoarthritis in Primary Care
TOOLS FOR PRACTICE
- Location, Location, Location: Treating patients with opioid disorder in primary care
- Does this patient taking prescription opioids have opioid use disorder?
- Buprenorphine-Naloxone for Pharmaceutical Opioid Use Disorder
- What is the Incidence of Iatrogenic Opioid Use Disorder?
- Spread the Word: Widespread Distribution of Naloxone to Decrease Opioid-Related Deaths
BEST SCIENCE (BS) MEDICINE PODCASTS
- Episode 404: Does your patient have an opioid use disorder?
- Episode 405: Buprenorphine-naloxone for pharmaceutical opioid use disorder
- Episode 406: How well is opioid agonist therapy managed in primary care?
COMPARING TREATMENT OPTIONS FOR PAIN (C-TOP)
MOTHERING AND OPIOIDS: ADDRESSING STIGMA – ACTING COLLABORATIVELY TOOLKIT
PATIENT RESOURCES
- Patient Resources and Engaging Individuals with Lived Experiences
CHOOSING WISELY CANADA – OPIOID WISELY
OTHER RESOURCES AND TOOLS
- AMA Section of Family Medicine Substance Use Disorder Toolbox of Fee Codes
- CPSA Announcement on Prescribing Changes for Buprenorphine/Naloxone
- Shared Zone Tools
- Alberta Opioid Reports
OTHER GUIDELINES AND TOOLKITS
- CRISM National Guideline for the Clinical Management of Opioid Use Disorder
- CAMH Buprenorphine/Naloxone for Opioid Dependence: Clinical Practice Guideline
- CMAJ National Injectable Opioid Agonist Treatment for Opioid Use Disorder Clinical Guideline
- Note: iOAT falls under the CPSA Standard of Practice: Safe Prescribing for Opioid Use Disorder and requires CPSA approval to initiate
- BC Centre for Substance Use Guidelines
- CFPC 2017 Canadian Guideline for Opioids for Chronic Non-Cancer Pain
- CFPC Best Advice Guide on Recovery-Oriented Mental Health and Addictions Care in Patient’s Medical Home